CLINICAL_TRIALS
trial_result
· 2015-04-09
Clinical Trial Update: Postmarketing Clinical Study on AO-128 [Phase 4]
Summary
Takeda's postmarketing Phase 4 study of AO-128 in impaired glucose tolerance has completed, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Impaired Glucose Tolerance (IGT) | Phase 4 | Status: COMPLETED | Results posted: 2015-04-09